Do you want to elevate your Science Communications during #WCLC24? The join us for the #IASLC Communications Committee Workshop on Saturday, Sept. 7 (14:30-16:30 PT) - Room 26B. You will engage w/all our expert speakers in a lively discussion, network, and exchange ideas w/peers!
International Association for the Study of Lung Cancer
Non-profit Organizations
Denver, Colorado 9,717 followers
Conquering thoracic cancers worldwide.
About us
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer. Founded in 1974, the association’s membership includes nearly 9,000 lung cancer specialists in over 100 countries. The IASLC's seeks to conquer thoracic cancers worldwide through educating scientists, medical professionals and the public on all aspects of lung cancer and other thoracic malignancies. The association publishes the Journal of Thoracic Oncology, a primary resource on the detection, prevention, diagnosis and treatment of lung cancer. Finally, each year the IASLC also hosts the IASLC World Conference on Lung Cancer (WCLC), the world's largest meeting dedicated solely to the study and science of thoracic cancers. The WCLC regularly draws 7,000 thoracic cancer specialists from over 100 countries.
- Website
-
http://www.iaslc.org/
External link for International Association for the Study of Lung Cancer
- Industry
- Non-profit Organizations
- Company size
- 11-50 employees
- Headquarters
- Denver, Colorado
- Type
- Nonprofit
- Founded
- 1974
- Specialties
- Journal of Thoracic Oncology (JTO), Thoracic Oncology, Lung Cancer, Cancer Research, Medical Education, and Science
Locations
-
Primary
Get directions
1775 N Sherman St
Denver, Colorado 80203, US
Employees at International Association for the Study of Lung Cancer
Updates
-
To help members navigate the current treatment options available for pts with resectable LC, the IASLC convened a global multidisciplinary expert panel to review data and provide guidelines/flow charts to select the optimal regimen for their patient. https://bit.ly/3LwKQiW #LCSM
-
-
In this special episode of #LungCancerConsidered in Greek, host Dr. Giannis Mountzios, from the Henry Dunant Hospital Center in Athens, Greece, leads a wide-ranging discussion on the application of precision medicine in oncology, focusing on molecular testing, genetic mutations such as KRAS and the effectiveness of liquid biopsy in #lungcancer diagnosis. With guests Dr. Valsamo Anagnostou, from the Johns Hopkins School of Medicine, and Dr Ferdinandos Skoulidis, from the University of Texas MD Anderson Cancer Center. Listen Now: https://bit.ly/LCCgreek2\ #LCSM
-
-
The phase 3 RATIONALE-312 study aimed to evaluate the efficacy & safety of tislelizumab chemotherapy as first-line treatment for ES-SCLC, which exhibited statistically significant clinical benefit & manageable safety compared w placebo chemotherapy. https://bit.ly/4akAXPN #LCSM
-
-
We are excited to announce our collaboration with 23andMe on the groundbreaking Lung Cancer Genetics Study! The goal: to learn more about the genetics of people living with #lungcancer in an effort to advance treatment discoveries. Sign up today at: https://lnkd.in/grZ2Pkbk #LCSM
-
-
New in ILCN: The increased burden of lung cancer on women underscores the necessity for gender-sensitive approaches, say Drs. Jyoti Patel and Khyati Somayaji Dasika. https://bit.ly/4fjuXKn #LCSM
-
Register today for #WCLC24 & discover a program designed for all disciplines & professional levels. The educational journey begins on Saturday September 7, with 17 curated workshops hosted by #IASLC Committees & Members. Learn More and Register Here: https://bit.ly/3A4pRBs #LCSM
-
-
This study focused on whether STAS could be a useful additional histologic descriptor to supplement the existing ones of VPI & LVI. These data support the recommendation to include STAS as a histologic descriptor for the 9th Edition of the TNM Classification of #lungcancer. https://bit.ly/3IZkx3x #LCSM
-
-
Whether you aim to advance your clinical practices, or contribute to oncological research, #ACLC24 is an essential event for anyone committed to combating #lungcancer at the forefront of medical science! Learn More/Register: https://lnkd.in/gxAXJSQB #LCSM
-
-
The R-classification for the 9th edition of stage classification of LC is proposed to retain the same overall framework/descriptors as the previous 8th, w/more precise definitions of descriptors. These refinements should facilitate application & further research. https://bit.ly/441RqX1 #LCSM
-